
SPDR Series Trust - State Street SPDR S&P Pharmaceuticals ETF
ARCAXPH cost to borrow surges to 13.26% — up 101% in one week, reflecting tightening share availability for the pharmacy ETF.
Snapshot as of 9 May 2026
No long-form analysis yet for XPH. Pulse alerts and the live data picture are available on ORTEX.
Open XPH on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for XPH — free to start on ORTEX.
Sign up for free →Open XPH on ORTEX